Vanguard Group Inc Adaptive Biotechnologies Corp Transaction History

Vanguard Group Inc

$5.46 Trillion
Q3 2024

A detailed history of Vanguard Group Inc transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Vanguard Group Inc holds 10,639,440 shares of ADPT stock, worth $62.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,639,440

Previous 10,226,911 4.03%

Holding current value

$62.2 Million

Previous $37 Million 47.14%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$3.37 - $5.12 $1.39 Million - $2.11 Million	412,529 Added 4.03%	10,639,440 $54.5 Million
Q2 2024 Aug 13, 2024	SELL	$2.34 - $3.96 $6.18 Million - $10.5 Million	-2,642,907 Reduced 20.54%	10,226,911 $37 Million
Q1 2024 May 10, 2024	BUY	$2.88 - $4.8 $294,145 - $490,243	102,134 Added 0.8%	12,869,818 $41.3 Million
Q4 2023 Feb 14, 2024	BUY	$3.46 - $5.33 $1.79 Million - $2.76 Million	518,642 Added 4.23%	12,767,684 $62.6 Million
Q3 2023 Nov 14, 2023	BUY	$5.07 - $8.44 $996,533 - $1.66 Million	196,555 Added 1.63%	12,249,042 $66.8 Million
Q2 2023 Aug 14, 2023	BUY	$6.19 - $8.78 $464,701 - $659,140	75,073 Added 0.63%	12,052,487 $80.9 Million
Q1 2023 May 15, 2023	BUY	$7.8 - $10.11 $1.43 Million - $1.85 Million	183,246 Added 1.55%	11,977,414 $106 Million
Q4 2022 Feb 10, 2023	BUY	$6.26 - $9.34 $766,130 - $1.14 Million	122,385 Added 1.05%	11,794,168 $90.1 Million
Q3 2022 Nov 14, 2022	BUY	$6.5 - $12.67 $620,158 - $1.21 Million	95,409 Added 0.82%	11,671,783 $83.1 Million
Q2 2022 Aug 12, 2022	BUY	$6.4 - $14.73 $3.11 Million - $7.15 Million	485,540 Added 4.38%	11,576,374 $93.7 Million
Q1 2022 May 13, 2022	BUY	$10.12 - $28.9 $602,605 - $1.72 Million	59,546 Added 0.54%	11,090,834 $154 Million
Q4 2021 Feb 14, 2022	BUY	$25.17 - $36.85 $1.02 Million - $1.5 Million	40,615 Added 0.37%	11,031,288 $310 Million
Q3 2021 Nov 12, 2021	BUY	$30.02 - $39.87 $24.4 Million - $32.4 Million	813,014 Added 7.99%	10,990,673 $374 Million
Q2 2021 Aug 13, 2021	BUY	$32.22 - $44.59 $328 Million - $454 Million	10,177,659 New	10,177,659 $416 Million

Others Institutions Holding ADPT

# of Institutions

202

Shares Held

146M

Call Options Held

68.8K

Put Options Held

42.5K

View Full List

About Adaptive Biotechnologies Corp

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $836M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

More about ADPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Adaptive Biotechnologies Corp Transaction History